Gold Spot US Dollar, Gold Futures, VanEck Gold Miners ETF. Read Stewart Thomson's latest article on Investing.com ...

Moderna MRNA announced fourth-quarter 2024 results. Though earnings and sales beat estimates, both metrics declined ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...

CureVac among global top 100 most fast-paced innovators for third consecutive year in acknowledgment of its innovative strength and extensive intellectual property portfolioThe company holds one of th ...

Health Secretary Robert F. Kennedy Jr. is a noted vaccine skeptic, and President Donald Trump has expressed concerns about ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

To come up with last week’s worst performers, we considered only the stocks with at least $2 billion in market capitalization ...

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

In the following chart, we are able to follow the development ... had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which ...

We list the best free Gantt chart software, to make it simple and easy to follow the progress of project management schedules, without a paid-for subscription. A Gantt chart is a very important ...

You can see that in the chart below: Because Cost of Sales ... And you can make that vaccine, that mRNA vaccine robotically, again, using AI, in about 48 hours." Honestly, this doesn't really ...